GRAIL Inc. Common Stock (GRAL) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
GRAIL Inc. Common Stock (GRAL) advanced +0.66% to $158.92 as options desks priced 57% call premium vs. 43% put protection around the $156 max-pain magnet. Solid 41% profit margin (-18% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection.
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the UBS Global Healthcare Conference in Palm Beach, F
Teradyne, Grail, Kratos Defense, FormFactor and Fabrinet have pulled back despite strong growth, setting up potential entry points in robotics, quantum and AI.
Felix Health has already announced it will offer GRAIL's Galleri multi-cancer early detection blood test to eligible adults in Ontario through virtual assessments and at-home collection, supported by data from the PATHFI
Natera is Thursday's IBD Stock Of The Day. Shares are hovering around their 21-day line, taking a breather after running up.
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2026 following the close of market
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +17.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on GRAL today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for GRAL. Explore sector supply chains on /butterfly.
Why GRAL Stock advanced +0.66% Today — RQD Quant Desk Flash. Solid 41% profit margin (-18% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.